Mechanisms of Cardiac Fibrosis Induced by Urokinase Plasminogen Activator
Open Access
- 1 June 2006
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 281 (22), 15345-15351
- https://doi.org/10.1074/jbc.m512818200
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Electrical interaction of mechanosensitive fibroblasts and myocytes in the heartBasic Research in Cardiology, 2005
- The distribution of cardiac macrophages in myocardial ischaemia and cardiomyopathyHistopathology, 2005
- Overexpression of Urokinase by Macrophages or Deficiency of Plasminogen Activator Inhibitor Type 1 Causes Cardiac Fibrosis in MiceCirculation Research, 2004
- Macrophage-Mediated Cardiac FibrosisCirculation Research, 2004
- Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureNature Medicine, 1999
- Mechanisms Underlying Spontaneous and Induced Ventricular Arrhythmias in Patients With Idiopathic Dilated CardiomyopathyCirculation, 1998
- Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cellsJournal of Cellular Physiology, 1996
- Immunohistochemistry in dilated cardiomyopathyEuropean Heart Journal, 1995
- Myocardial fibrosis: functional significance and regulatory factorsCardiovascular Research, 1993
- Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.JCI Insight, 1984